|
||||||||||||||||||
|
||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||||||||||||
Questions? Please consult our answers to frequently asked questions at http://www.ebioscience.com/faq. DescriptionThe Mouse TrueBlotTM Western Blot Kit contains the critical supporting reagents, buffers, and substrates for immunoprecipitation and Western blotting of samples using TrueBlotTM second step immunoblotting reagents in conjunction with your own primary IP antibody and primary (Mouse IgG) Western blotting antibody. TrueBlotTM technology enables unhindered detection of protein bands of interest which would otherwise be obscured by the presence of reduced & denatured heavy and light chain immunoglobulin in the blot (as detected by the conventional immunoblotting HRP anti-mouse IgG reagent). Mouse IgG TrueBlotTM ULTRA is the unique horseradish peroxidase conjugated anti-mouse IgG immunoblotting second step reagent which enables detection of immunoblotted target protein bands, without hindrance by interfering immunoglobulin heavy and light chains from your IP antibody. Use it in place of your usual HRP anti-mouse IgG immunoblotting second step reagent. It is easy to generate publication-quality IP/WB data with Mouse IgG TrueBlotTM ULTRA. Note that there are two key procedural considerations: 1. Immunoprecipitate should be completely reduced. 2. Milk should be used as the blocking protein for the immunoblot. The Mouse TrueBlotTM Western Blot Kit components are sufficient for 25 miniblots. Components:
Applications ReportedFor research use only, not for diagnostic or therapeutic use. Mouse TrueBlot™ WB Kit has been reported for use in immunoblotting (WB). Applications TestedMouse IgG TrueBlot™ ULTRA is ideal for use in protocols involving immunoblotting of immunoprecipitated proteins. TrueBlot™ preferentially detects the non-reduced form of mouse IgG over the reduced, SDS-denatured form of IgG. When the immunoprecipitate is fully reduced immediately prior to SDS-gel electrophoresis, reactivity of Mouse IgG TrueBlot™ ULTRA with the 55 kDa heavy chains and the 23 kDa light chains of the immunoprecipitating antibody is minimized thereby eliminating interference by the heavy and light chains of the immunoprecipitating antibody in IP/immunoblotting applications. Applications include studies examining post-translational modification (e.g., phosphorylation or acetylation) or protein-protein interactions. Related ProductsCat. 88-1488 Goat TrueBlot™ Set (includes 2.5 ml IP Beads, binds 1.0mg Ig/ml beads) Cat. 88-1688 Rabbit TrueBlot™ Set (includes 2.5 ml IP Beads, binds 2.5mg Ig/ml beads) Cat. 00-8811 TrueBlot™ anti-Mouse Ig IP Beads (Binds 0.4mg Ig/ml beads) Cat. 18-8814 Goat TrueBlot™: Horseradish Peroxidase (HRP) anti-goat IgG Cat. 18-8816 Rabbit TrueBlot™: Horseradish Peroxidase (HRP) anti-rabbit IgG Experimental ProceduresProcedure: Preparation of Immunoprecipitated Sample for SDS-PAGE
Procedure: Immunoblotting (Western Blotting, WB)
Other Procedural Notes1. Titration of primary IP antibody. Titration of the immunoprecipitating antibody is recommended (e.g., 1-5 µg / 107 cells / 1 ml lysate). Typically, 2 µg is a sufficient amount of antibody to maximally immunoprecipitate most antigens in 1 ml of extract from 1 x 107 cells. Using as little IP antibody as possible minimizes potential contamination of SDS reduced sample with nonreduced immunoprecipitating antibody light chain. 5 µg of immunoprecipitating antibody per ml of extract from 0.5 x 107 - 1.0 x 107 cells yields sample loads of 0.5-1.5 µg immunoprecipitating antibody and precipitates from1 x 106- 3 x 106 cells. Mouse IgG TrueBlot™ will not improve the specificity of immunoblotting antibody. If the immunoblotting antibody cross-reacts with proteins other than the target, the bound immunoblotting antibody will be detected by TrueBlot™. 2. Blocking the immunoblot. Mouse IgG TrueBlot™ has been extensively tested. It is recommended to block the blot in 5% TrueBlot™ Blocker in TrueBlot™ Assay Buffer overnight, which will significantly reduce the background. The use of BSA for blocking is specifically not recommended. 3. Positive control. Mouse IgG TrueBlot™ will detect SDS-denatured, non-reduced mouse IgG. A 20 ng sample of non-reduced, immunoprecipitating antibody can be included in the immunoblot as a positive control to ensure positive performance of TrueBlot™. 4. Negative control. Sample containing 0.5-2.0 µg of reduced mouse IgG (prepared and run immediately as described in Sample Preparation) can be included as a negative control to ensure that TrueBlot™ does not detect the heavy and light chain of the immunoprecipitating antibody. Other potential controls include omitting the cell extract during the IP, omitting the IP antibody during the IP, or omitting the immunoblotting antibody. 5. SDS-PAGE. Mouse IgG TrueBlot™ has been tested in procedures that employed anti-oxidant in the running buffer, staining of the membrane with Ponceau S Solution (Sigma) followed by destaining with 20% acetic acid/30% methanol, and air drying the membrane for 1 hour at room temperature after transfer and then rewetting in methanol and equilibration in Buffer A (described in Immunoblotting Protocol) before blocking. These modifications of the protocol gave results identical to the Immunoblotting Protocol. The Immunoblotting Protocol has not included these variations. Additional information: For updated information on this product. Experimental Example
Caspase-7 was immunoprecipitated from 5 x 106 Jurkat cells using 5 µg mouse anti-caspase-7 (Cat. No. 14-6697) and 50 µl of packed protein-G beads (Amersham). Immunoprecipitate was solubilized in 100 µl NuPAGE LDS sample buffer (Invitrogen) containing NuPAGE samples reducing agent (dithiothreitol) (Invitrogen). Beads were pelleted and 10 µl, corresponding to antigen immunoprecipitated from 5 x 105 cells and 0.5 µg immunoprecipitating antibody, were electrophoresed on 4-12% minigels (Invitrogen) and transferred to Immobilon-P membranes (Millipore). Membranes were blocked with 5% lowfat dry milk in Buffer A (25 mM Tris, pH 7.3, 0.15 M NaCl, 0.1% Tween-20) for 1 hour at room temperature. Caspase-7 was immunoblotted with 2 µg anti-caspase-7 per ml in 10 ml of Buffer A containing 2% milk for 2 hours at room temperature. After washing with Buffer A the membranes were incubated with Mouse IgG TrueBlot™ at a dilution of 1:1,000 in Buffer A containing 2% milk for 1 hour at room temperature. Membranes were washed with Buffer A and developed with ECL reagent (Amersham) and exposed to film. Troubleshooting
TrueBlot™ is a Trademark of eBioscience - Patent Pending |
|||||||||||||||||||||||||||||||||||||||||||||||
![]() |
![]() |
|
Copyright © 2000-2009 eBioscience, Inc. For Research Use Only. Not for use in diagnostic procedures. Not for further distribution without written consent. |